Literature DB >> 18039091

Adventures in hepatocarcinogenesis.

Henry C Pitot1.   

Abstract

Neoplasia is a heritably altered, relatively autonomous growth of tissue. Hepatocarcinogenesis, the pathogenesis of neoplasia in liver, as modeled in the rat exhibits three distinct, quantifiable stages: initiation, promotion, and progression. Simple mutations and/or epigenetic alterations may result in the irreversible stage of initiation. The stage of promotion results from selective enhancement of cell replication and selective inhibition of cellular apoptosis of initiated cells dependent on the genetic and/or epigenetic alterations of the latter. The irreversible stage of progression results from initial karyotypic alterations that evolve into greater degrees of genomic instability. The initial genomic alteration in the transition from promotion to progression may involve primarily epigenetic mechanisms driven by epigenetic and genetic alterations fixed during the stage of promotion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18039091     DOI: 10.1146/annurev.pathol.2.010506.092027

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   23.472


  9 in total

1.  Gene deletions and amplifications in human hepatocellular carcinomas: correlation with hepatocyte growth regulation.

Authors:  Michael A Nalesnik; George Tseng; Ying Ding; Guo-Sheng Xiang; Zhong-liang Zheng; YanPing Yu; James W Marsh; George K Michalopoulos; Jian-Hua Luo
Journal:  Am J Pathol       Date:  2012-02-08       Impact factor: 4.307

Review 2.  Human adult stem cells as the target cells for the initiation of carcinogenesis and for the generation of "cancer stem cells".

Authors:  James E Trosko
Journal:  Int J Stem Cells       Date:  2008-11       Impact factor: 2.500

3.  Effects of sorafenib and cisplatin on preneoplastic foci of altered hepatocytes in fetal turkey liver.

Authors:  Bettina Kaestner; Karsten Spicher; Ulrich Jaehde; Harald Enzmann
Journal:  Toxicol Res (Camb)       Date:  2016-11-02       Impact factor: 3.524

4.  Chronic administration of 2-acetylaminofluorene alters the cellular iron metabolism in rat liver.

Authors:  Svitlana I Shpyleva; Levan Muskhelishvili; Volodymyr P Tryndyak; Igor Koturbash; Erik J Tokar; Michael P Waalkes; Frederick A Beland; Igor P Pogribny
Journal:  Toxicol Sci       Date:  2011-07-23       Impact factor: 4.849

5.  Single-walled carbon nanotube-induced mitotic disruption.

Authors:  L M Sargent; A F Hubbs; S-H Young; M L Kashon; C Z Dinu; J L Salisbury; S A Benkovic; D T Lowry; A R Murray; E R Kisin; K J Siegrist; L Battelli; J Mastovich; J L Sturgeon; K L Bunker; A A Shvedova; S H Reynolds
Journal:  Mutat Res       Date:  2011-12-08       Impact factor: 2.433

6.  Transcriptomic responses provide a new mechanistic basis for the chemopreventive effects of folic acid and tributyrin in rat liver carcinogenesis.

Authors:  Aline H Guariento; Kelly S Furtado; Aline de Conti; Adriana Campos; Eduardo Purgatto; Jéssica Carrilho; Elvira Maria Guerra Shinohara; Volodymyr Tryndyak; Tao Han; James C Fuscoe; Sharon A Ross; Frederick A Beland; Igor P Pogribny; Fernando S Moreno
Journal:  Int J Cancer       Date:  2014-02-22       Impact factor: 7.396

7.  Epigenetic Contributions to the Relationship between Cancer and Dietary Intake of Nutrients, Bioactive Food Components, and Environmental Toxicants.

Authors:  L Joseph Su; Somdat Mahabir; Gary L Ellison; Laura A McGuinn; Britt C Reid
Journal:  Front Genet       Date:  2012-01-09       Impact factor: 4.599

8.  Epigenetic factors in cancer risk: effect of chemical carcinogens on global DNA methylation pattern in human TK6 cells.

Authors:  Ali M Tabish; Katrien Poels; Peter Hoet; Lode Godderis
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

Review 9.  Evidence for immortality and autonomy in animal cancer models is often not provided, which causes confusion on key issues of cancer biology.

Authors:  Xixi Dou; Pingzhen Tong; Hai Huang; Lucas Zellmer; Yan He; Qingwen Jia; Daizhou Zhang; Jiang Peng; Chenguang Wang; Ningzhi Xu; Dezhong Joshua Liao
Journal:  J Cancer       Date:  2020-03-04       Impact factor: 4.207

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.